References
- Ahmad, M., Zeitlin, I. J., and Parratt, J. R., The release of kininase from rat isolated hearts during myocardial ischaemia. Immunopharmacol., 33, 299-300 (1996) https://doi.org/10.1016/0162-3109(96)00047-1
- Bhoola, K. D., Figueroa, C. D., and Worthy, K., Bioregulation of kinins, kallikrein, kininogens, and kininases. Pharmacol. Rev., 44(1), 1-80 (1992)
- Campbell, J. D., Anastasopoulos, F., Duncan, M. A., James, M. G., Kladis, A., and Briscoe, A. T., Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. J. Pharmacol. Exper. Therapeut., 287(2), 567-577 (1998)
- Dendorfer, A., Wolfrum, S., Wellhoner, P., Korsman, K., and Dominaik, P., Intravascular and interstitial degradation of bradykinin in isolated rat heart. Br. J. Pharmacol., 122, 1179- 1187 (1997) https://doi.org/10.1038/sj.bjp.0701501
- Dumoulin, J. M., Adam, A., Rouleau, L. J., and Lamontagne, D., Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed. J. Cardiovasc. Pharmacol., 37, 359-366 (2001) https://doi.org/10.1097/00005344-200104000-00002
- Erdos, E. G., Some old and some new ideas on kinin metabolism. J. Cardiovasc. Pharmacol.,15(Suppl. 6), S20- S24 (1990) https://doi.org/10.1097/00005344-199015061-00005
- Ersahin, C. and Simmons, W. H., Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation. J. Cardiovasc. Pharmacol., 30, 96-101 (1997) https://doi.org/10.1097/00005344-199707000-00014
- Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., and Whitehouse, E., Electrospray ionization for mass spectrometry of large biomolecules. Science, 249, 64-71 (1989) https://doi.org/10.1126/science.2164259
- Lamontagne, D., Nadeau, R., and Adam, A., Effect of enlaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart. Br. J. Pharmacol., 115, 476-478 (1995) https://doi.org/10.1111/j.1476-5381.1995.tb16357.x
- Linz, W., Wiemer, G., Gholke, P., Unger, T., and Scholkens, B., A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49 (1995)
- Moshi, M. J., Zeitlin, I. J., Wainwright, C. L., and Parratt, J. R., Acid Optimum kininogenase in canine myocardium and aorta. J. Cardiovasc. Res., 26, 367-370 (1992) https://doi.org/10.1093/cvr/26.4.367
- Piedimonte, G., Nadel, J. A., Long, C. S., and Hoffman, J. I. E., Neutral Endopeptidase in the heart: Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation. Cir. Res., 75, 770-779 (1994) https://doi.org/10.1161/01.RES.75.4.770
- Raut, R., Rouleau, L. J., and Blais, C., Bradykinin metabolism in the postinfarcted rat heart: Role of ACE and neutral endopeptidase 24.11. Am. J. Physiol., 276 (Heart Circ. Physiol. 45), H1769-H1779 (1999)
- Shrimpton, C. N., Smith, A. I., and Lew, R. A., Soluble metalloendopeptidases and neuroendocrine signaling. Endo. Rev., 23(5), 647-664 (2002) https://doi.org/10.1210/er.2001-0032
- Skidgel, R. A., Bradykinin-degrading enzymes: Structure, Function, Distribution, and potential roles in cardiovascular pharmacology. J. Cardiovasc. Pharmacol., 20(Suppl. 9), S4- S9 (1992) https://doi.org/10.1097/00005344-199200209-00003
- Skidgel, R. A., Davis, R. M., and Tan, F., Human carboxypeptidase M. J. Biol. Chem., 264(4), 2236-2241 (1989)
- Yamada, H., Fabris, B., Allen, A. M., Jackson, B., Johnston, C. I., and Mendelson, A. O., Localization of angiotensin converting enzyme in rat heart. Cir. Res., 68, 141-149 (1991) https://doi.org/10.1161/01.RES.68.1.141